Skip to main content
. 2025 Nov 20;26(22):11211. doi: 10.3390/ijms262211211
AR Androgen receptor
CAF Cancer-associated fibroblast
ECM Extracellular matrix
EMT Epithelial–mesenchymal transition
ER Estrogen receptor
HIF Hypoxia-inducible factor
IBC, NST Invasive breast carcinoma of no special type
iCAF Inflammatory cancer-associated fibroblast
IM Immunomodulatory subtype
LAR Luminal androgen receptor subtype
M Mesenchymal subtype
MMP Matrix metalloproteinase
MSL Mesenchymal stem-like subtype
myCAF Myofibroblast-like cancer-associated fibroblast
NAC Neoadjuvant chemotherapy
pCR Pathological complete response
PR Progesterone receptor
TGF-β Transforming growth factor beta
TME Tumor microenvironment
TNBC Triple-negative breast cancer
VDR Vitamin D receptor